TrialInvestigational new drugs2017

A phase 1 study of the pharmacokinetics of nucleoside analog trifluridine and thymidine phosphorylase inhibitor tipiracil (components of TAS-102) vs trifluridine alone.

James M Cleary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.